Therefore, to gain further insights into the proportion of cells in specific cycling phases, we performed single-cell RNA sequencing (scRNA-seq; n = 37,466 viable single cells) with 10 GBM cell lines, cultured for 3 days in either CSF or GM (fig. The gene discussed is CSF2; the disease is glioblastoma.